|
DIANOGEN, a privately owned company with headquarters in Huenenberg near Zug in Switzerland, is a technology specialist in the field of magnetic and non-magnetic micro- and nanoparticles (beads) and high-tech polymer modification.
Our scientific portfolio also includes cutting-edge new approaches in medical therapy (e.g. AIDS therapy, tumor therapy) using contactless controllable drug carriers. DIANOGEN's aim is to further develop and commercialise its biomedical/nanobiotechnology portfolio which has been built-up during the past 20 years. These technologies can be sold, licensed-out or further developed/joint development with industrial and/or financial partners.
Unique selling points of DIANOGEN's technology/products in comparison to established technologies/products are the following aspects:
- Synthesis within minutes (main competitors: 15-40 hrs)
â–º cost and personnel saving
- Selectable polymer types (main competitors: mostly one product, e.g. polystyrene, silica gel)
â–º better application optimisation
- Number of adaptable product and process parameters (main competitors: one major process procedure)
â–º customised products easily achievable
- Sizes adaptable from 50 nm to 3,000 μm (main competitors: offer standard sizes 50 -100 nm, 0.5 to 1 μm or 1- 4 μm)
â–º better application adaptation and extended application spectrum
DIANOGEN develops and offers innovative scientific/technological know how in the following areas:
- AIDS Therapy
- Biocompatible Polymers/Gels for Medical Implants or Wound Dressing
- Biopolymers / Hydrogels / Plastics for Bioscience and Medicine
- Carriers/Matrices for (Stem) Cell Immobilisation, Separation and Cultivation
- Cryopreservation
- Diagnostics
- Magnetic/Non-Magnetic Polymer Carriers / Beads
- Nanotechnology
- Radiation Technology for Polymer/Plastic Modification
- Tumor Therapy
DIANOGEN is looking for investors to strengthen its research and development activities.
|
